The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Article in EBioMedicine (October 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in EBioMedicine (October 2023)
Article in Microorganisms (July 2023)
Article in Scientific Reports (April 2023)